Connecting the DOTS
Connecting the DOTS
The four factors that drive contagion
Connecting the DOTS
Connecting the DOTS

The four factors that drive contagion

The four factors that drive contagion

SARS
Opinion: Don’t Disparage the Pace of COVID-19 Research
Opinion: Don’t Disparage the Pace of COVID-19 Research
John D. Loike, Salomon Amar | Jun 22, 2020
Fast science—with all its warts—is making unprecedented progress in the fight against COVID-19.
Timeline: Human Coronavirus Discoveries
Timeline: Human Coronavirus Discoveries
Shawna Williams | Jun 4, 2020
Download our poster of the biggest milestones, from the discovery of the viral family in humans in the 1960s to the identification of SARS-CoV-2.
A Brief History of Human Coronaviruses
A Brief History of Human Coronaviruses
Shawna Williams | Jun 2, 2020
Milder, cold-causing members of this pathogenic viral family long remained under the radar, although they aren’t entirely harmless.
<strong>Tailor-Made: Empowering SARS-CoV-2 Researchers Worldwide</strong>
Tailor-Made: Empowering SARS-CoV-2 Researchers Worldwide
The Scientist Creative Services Team | May 26, 2020
Arbor Biosciences is offering free SARS-CoV-2 myBaits kits to all researchers.  
SARS-CoV-2 Protein Hampers Innate Immune Reaction In Vitro
SARS-CoV-2 Protein Hampers Innate Immune Reaction In Vitro
Abby Olena | May 21, 2020
The viral protein known as ORF3b limits the induction of the type I interferon response, which typically alerts other immune system components to the presence of a virus, in cultured cells.
NIH Cancels Funding for Bat Coronavirus Research Project
NIH Cancels Funding for Bat Coronavirus Research Project
Shawna Williams | Apr 28, 2020
The abrupt termination comes after the research drew President Trump’s attention for its ties to the Wuhan Institute of Virology.
Study Questions if School Closures Limit the Spread of COVID-19
Study Questions if School Closures Limit the Spread of COVID-19
Ashley Yeager | Apr 7, 2020
School shutdowns might have a relatively small effect on preventing the transmission of SARS-CoV-2, a new meta-analysis suggests, though the preliminary data point to the need for more studies.
Blood Pressure Meds Point the Way to Possible COVID-19 Treatment
Blood Pressure Meds Point the Way to Possible COVID-19 Treatment
Ashley Yeager | Apr 2, 2020
There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.
Cells&rsquo; Response to SARS-CoV-2 Different from Flu, RSV
Cells’ Response to SARS-CoV-2 Different from Flu, RSV
Abby Olena | Mar 31, 2020
The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.